Visa vs Eli Lilly
Comparación de la capitalización de mercado a lo largo del tiempo
Visa
$688.7B
Puesto #19
Eli Lilly
$1.08T
Puesto #15
Capitalización de mercado a lo largo del tiempo
Momentos clave
- Visa superó a Eli Lilly para 2009
- Eli Lilly superó a Visa para 2023
Comparación año por año
| Año | Visa | Eli Lilly | Líder |
|---|---|---|---|
| 2026 | $688.7B | $1.08T | Eli Lilly |
| 2025 | $579.7B | $955.1B | Eli Lilly |
| 2024 | $518.7B | $681.0B | Eli Lilly |
| 2023 | $424.0B | $510.9B | Eli Lilly |
| 2022 | $335.7B | $317.5B | Visa |
| 2021 | $347.6B | $236.5B | Visa |
| 2020 | $348.7B | $142.4B | Visa |
| 2019 | $297.7B | $108.7B | Visa |
| 2018 | $207.7B | $93.6B | Visa |
| 2017 | $178.3B | $66.6B | Visa |
| 2016 | $121.1B | $56.5B | Visa |
| 2015 | $119.5B | $63.1B | Visa |
| 2014 | $100.3B | $50.3B | Visa |
| 2013 | $84.6B | $36.0B | Visa |
| 2012 | $57.1B | $33.5B | Visa |
| 2011 | $38.0B | $27.0B | Visa |
| 2010 | $26.1B | $21.6B | Visa |
| 2009 | $32.2B | $20.8B | Visa |
| 2008 | $19.2B | $22.2B | Eli Lilly |